Profile
| Metric | Value |
|---|---|
| Full Name | Zoetis Inc. |
| Ticker | NYSE: ZTS |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | zoetis.com |
| Employees | 13,800 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $124.65 | |
| Price, 1D Change | -0.50% | |
| Market Cap | $55B | |
| TTM Dividend Yield | 1.60% | |
| PE Ratio | 21.00 | |
| Beta | 0.61 | |
| Revenue | $9B | |
| Revenue, 1Y Change | +8.33% | |
| EPS | $5.47 | |
| EPS, 1Y Change | +7.79% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.50 | |
| Next Ex-Dividend | $0.53 | |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.47 | |
| EPS Estimate | $6.34 | |
| EPS Est. Change | +15.99% | |
| Revenue | $9.26B | |
| Revenue Estimate | $9.44B | |
| Revenue Est. Change | +2.00% | |
| Current Price | $124.65 | |
| Price Target | - | $158.22 |
| Price Tgt. Change | - | +26.93% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.43 | $5.07 | -6.62% | |
| $5.88 | $5.47 | -7.03% | |
| $6.34 | N/A | +15.99% | |
| $6.79 | N/A | +24.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $8.52B | $8.54B | +0.23% | |
| $9.25B | $9.26B | +0.04% | |
| $9.44B | N/A | +2.00% | |
| $9.92B | N/A | +7.13% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -26.40% | |
| Price, 3Y | -22.54% | |
| Market Cap, 1Y | -27.68% | |
| Market Cap, 3Y | -26.40% | |
| Revenue, 1Y | +8.33% | |
| Revenue, 3Y | +19.03% | |
| EPS, 1Y | +7.79% | |
| EPS, 3Y | +27.91% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $124.65 | |
| SMA 200 | $145.40 | |
| SMA 200 vs Price | +16.65% | |
| SMA 50 | $122.85 | |
| SMA 50 vs Price | -1.45% | |
| Beta | 0.61 | |
| ATR | $2.79 | |
| 14-Day RSI | 48.06 | |
| 10-Day Volatility | 23.82% | |
| 1-Year Volatility | 29.13% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.50 | |
| Upcoming | $0.53 | |
| Dividend Yield | 1.39% | |
| Total Dividend | $1.73 | |
| Dividends Paid | $786.00M | |
| Payout Ratio | 31.49% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $9.26B | |
| EPS | $5.47 | |
| Gross Profit | $6.54B | |
| Gross Margin | 70.62% | |
| Operating Profit | $3.39B | |
| Operating Margin | 36.65% | |
| Net Income | $2.50B | |
| Net Margin | 26.86% | |
| EBITDA | $3.86B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.42 | |
| Current Ratio | 1.75 | |
| Quick Ratio | 1.08 | |
| Interest Coverage | 14.92 | |
| F-Score | 7 | |
| Altman Z-Score | 6.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 21.00 | |
| PS Ratio | 5.85 | |
| PB Ratio | 10.18 | |
| EV/EBITDA | 14.94 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $4.77B | |
| Cash & Equivalents | $1.99B | |
| Total Assets | $14.24B | |
| Current Assets | $5.99B | |
| Total Liabilities | $9.47B | |
| Current Liabilities | $3.41B | |
| Total Debt | $6.80B | |
| Short Term Debt | $1.40B | |
| Accounts Payable | $433.00M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $5.86B | |
| Operating Expenses | $3.15B | |
| Cost Of Goods Sold | $2.72B | |
| SG&A | $2.32B | |
| D&A | $497.00M | |
| Interest Expense | $225.00M | |
| Income Tax | $637.00M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $2.95B | |
| CFI | -$315.00M | |
| CFF | -$2.66B | |
| Capex | $655.00M | |
| Free Cash Flow | $2.30B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Barclays | ||
| BTIG | → | |
| Keybanc | ||
| Stifel | → | |
| BTIG | → | |
| Morgan Stanley | → | |
| UBS | → | |
| JP Morgan | → | |
| UBS | → | |
| Argus Research | → |
Analyst sentiment
Institutional ownership
Screeners with ZTS
FAQ
What is the ticker symbol for Zoetis Inc.?
The ticker symbol for Zoetis Inc. is NYSE:ZTS
Does Zoetis Inc. pay dividends?
Yes, Zoetis Inc. pays dividends. The last payment was $0.50, with an ex-dividend date on October 31, 2025
What sector is Zoetis Inc. in?
Zoetis Inc. is in the Healthcare sector
What industry is Zoetis Inc. in?
Zoetis Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Zoetis Inc. based in?
Zoetis Inc. is headquartered in United States
When did Zoetis Inc. go public?
Zoetis Inc. initial public offering (IPO) was on February 1, 2013
Is Zoetis Inc. in the S&P 500?
Yes, Zoetis Inc. is included in the S&P 500 index
Is Zoetis Inc. in the NASDAQ 100?
No, Zoetis Inc. is not included in the NASDAQ 100 index
Is Zoetis Inc. in the Dow Jones?
No, Zoetis Inc. is not included in the Dow Jones index
When was Zoetis Inc. last earnings report?
Zoetis Inc.'s most recent earnings report was on November 4, 2025
When does Zoetis Inc. report earnings?
The next expected earnings date for Zoetis Inc. is February 12, 2026
Data Sources & References
- ZTS Official Website www.zoetis.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1555280/000155528025000274/0001555280-25-000274-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1555280/000155528025000102/0001555280-25-000102-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- ZTS Profile on Yahoo Finance finance.yahoo.com/quote/ZTS
- ZTS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zts